Korean regenerative medicine company REV-MED showcased its NovaStem BMAC, a cutting-edge bone marrow aspirate concentrate extraction kit, at MEDICA 2023, the world’s largest medical exhibition, held in Düsseldorf, Germany.
About MEDICA
MEDICA is the world's most prestigious medical device exhibition, attracting approximately 5,000 companies globally each year to present their innovative products and technologies. Running from November 13 to 16, MEDICA 2023 marks a milestone for REV-MED as a platform to elevate Korea’s standing in regenerative medicine.
NovaStem BMAC: Transforming Regenerative Therapy
NovaStem BMAC is a highly advanced kit designed for the efficient extraction of concentrated bone marrow aspirate. The procedure has been validated through extensive research and clinical trials, earning recognition as a new medical technology by Korea’s Ministry of Health and Welfare.
Clinical applications have demonstrated significant improvements for patients with:
- Kellgren-Lawrence (KL) Grades 2–3: Moderate knee osteoarthritis.
- International Cartilage Repair Society (ICRS) Grades 3–4: Severe cartilage defects.
The therapy alleviates knee pain and enhances joint functionality, offering a promising solution for regenerative treatments.
A Vision for Global Regenerative Medicine
Edward BG Shin, CEO of REV-MED, emphasized, “Participating in MEDICA 2023 is a pivotal moment for REV-MED to showcase our advancements in regenerative medicine to the global community. We aim to position Korea as a leader in this critical field.”
With innovative products like NovaStem BMAC, REV-MED continues to drive advancements in regenerative medicine, contributing to improved patient outcomes worldwide.
Source: https://www.mbn.co.kr/news/life/4978822
Korean regenerative medicine company REV-MED showcased its NovaStem BMAC, a cutting-edge bone marrow aspirate concentrate extraction kit, at MEDICA 2023, the world’s largest medical exhibition, held in Düsseldorf, Germany.
About MEDICA
MEDICA is the world's most prestigious medical device exhibition, attracting approximately 5,000 companies globally each year to present their innovative products and technologies. Running from November 13 to 16, MEDICA 2023 marks a milestone for REV-MED as a platform to elevate Korea’s standing in regenerative medicine.
NovaStem BMAC: Transforming Regenerative Therapy
NovaStem BMAC is a highly advanced kit designed for the efficient extraction of concentrated bone marrow aspirate. The procedure has been validated through extensive research and clinical trials, earning recognition as a new medical technology by Korea’s Ministry of Health and Welfare.
Clinical applications have demonstrated significant improvements for patients with:
The therapy alleviates knee pain and enhances joint functionality, offering a promising solution for regenerative treatments.
A Vision for Global Regenerative Medicine
Edward BG Shin, CEO of REV-MED, emphasized, “Participating in MEDICA 2023 is a pivotal moment for REV-MED to showcase our advancements in regenerative medicine to the global community. We aim to position Korea as a leader in this critical field.”
With innovative products like NovaStem BMAC, REV-MED continues to drive advancements in regenerative medicine, contributing to improved patient outcomes worldwide.
Source: https://www.mbn.co.kr/news/life/4978822